Thursday’s Highlights at Noon: Synergy Pharmaceuticals Inc (SGYP), Biocept Inc (BIOC), Civeo Corp (CVEO), Advaxis (ADXS), Curis Inc (CRIS)

By Carrie Williams

So far Thursday, January 24, NASDAQ is up 0.82% and the S&P is up 0.23%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Synergy Pharmaceuticals Inc (SGYPResearch Report), Biocept Inc (BIOCResearch Report), Civeo Corp (CVEOResearch Report), Advaxis (ADXSResearch Report) and Curis Inc (CRISResearch Report).

Synergy Pharmaceuticals Inc is up 36.31% in midday trading to $0.46. Shares opened today at $0.34. The company has a 52-week low of $0.07 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $2.00, marking a 487.54% potential upside from current levels. In a report issued on October 26, BTIG analyst Tim Chiang downgraded SGYP to Hold.

Biocept Inc is up 12.04% in midday trading to $2.14. Shares opened today at $1.91. The company has a 52-week low of $0.66 and a 52-week high of $0.00.

Civeo Corp is up 10.84% in midday trading to $2.25. Shares opened today at $2.03. The company has a 52-week low of $1.12 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $4.00, marking a 97.04% potential upside from current levels. In a report issued on October 31, Craig-Hallum analyst Mike Malouf maintained a Buy rating on CVEO, with a price target of $4, which represents a potential upside of 97% from where the stock is currently trading.

See today’s analyst top recommended stocks >>

Advaxis is up 10.55% in midday trading to $0.32. Shares opened today at $0.29. The company has a 52-week low of $0.18 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $3.00, marking a 934.48% potential upside from current levels. In a report released today, H.C. Wainwright analyst Swayampakula Ramakanth maintained a Hold rating on ADXS. Separately, on December 17, Alliance Global Partners’ James Molloy maintained a Buy rating on the stock and has a price target of $3.

See today’s analyst top recommended stocks >>

Curis Inc is up 10.22% in midday trading to $1.27. Shares opened today at $1.15. The company has a 52-week low of $0.60 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $3.00, marking a 160.87% potential upside from current levels. In a report issued on November 1, Robert W. Baird analyst Brian Skorney maintained a Buy rating on CRIS, with a price target of $3, which implies an upside of 161% from current levels.

Trending Stocks Based on Insider Activity >>